Literature DB >> 20627872

Frequent silencing of popeye domain-containing genes, BVES and POPDC3, is associated with promoter hypermethylation in gastric cancer.

Mirang Kim1, Hay-Ran Jang, Keeok Haam, Tae-Wook Kang, Jeong-Hwan Kim, Seon-Young Kim, Seung-Moo Noh, Kyu-Sang Song, June-Sik Cho, Hyun-Yong Jeong, Jin Cheon Kim, Hyang-Sook Yoo, Yong Sung Kim.   

Abstract

The Popeye domain-containing (POPDC) genes BVES, POPDC2 and POPDC3 encode proteins that regulate cell-cell adhesion and cell migration during development. Herein, we report the frequent downregulation of BVES and POPDC3 by promoter hypermethylation in gastric cancer. POPDC expression in 11 gastric cancer cell lines and 96 paired gastric tumor and normal adjacent tissues was analyzed with quantitative reverse transcription-polymerase chain reaction. The methylation status of BVES and POPDC3 was analyzed with methylated DNA immunoprecipitation sequencing, bisulfite sequencing and pyrosequencing. Expression of BVES and POPDC3 was downregulated in 73% of the gastric cancer cell lines and in 69% (BVES) and 87% (POPDC3) of the gastric cancer tissues. The BVES and POPDC3 promoter regions were hypermethylated in the gastric cancer cell lines in which they were silenced. Combined treatment with a DNA methylation inhibitor and a histone deacetylase inhibitor strongly induced BVES and POPDC3 expression. BVES and POPDC3 were hypermethylated in 69% (BVES) and 64% (POPDC3) of the gastric cancer tissues. We knocked down POPDC3 expression with short hairpin RNAs and examined the consequences on cell migration and invasion. Knockdown of POPDC3 in SNU-216 cells caused increased cell migration and invasion. Thus, epigenetic inactivation of BVES and POPDC3 occurs frequently in gastric tumors and may promote gastric cancer cell migration and invasion.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20627872     DOI: 10.1093/carcin/bgq144

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  26 in total

1.  BVES inhibition triggers epithelial-mesenchymal transition in human hepatocellular carcinoma.

Authors:  Ping Han; Yu Fu; Min Luo; Jiayi He; Jingmei Liu; Jiazhi Liao; Dean Tian; Wei Yan
Journal:  Dig Dis Sci       Date:  2014-01-18       Impact factor: 3.199

2.  Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.

Authors:  Deng Luo; Hua Huang; Ming-Liang Lu; Gong-Fang Zhao; Jiang Chang; Meng-Yao Zheng; Yan Wang
Journal:  Pathol Oncol Res       Date:  2011-11-23       Impact factor: 3.201

3.  Netrin-1 promotes cell migration and invasion by down-regulation of BVES expression in human hepatocellular carcinoma.

Authors:  Ping Han; Yu Fu; Jingmei Liu; Yunwu Wang; Jiayi He; Jin Gong; Mengke Li; Qinghai Tan; Dongxiao Li; Yixing Luo; Jian Han; Jiqiao Liu; Wei Tu; Ying Wang; Dean Tian; Wei Yan
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

4.  BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma.

Authors:  Christopher S Williams; Baolin Zhang; J Joshua Smith; Ashwath Jayagopal; Caitlyn W Barrett; Christopher Pino; Patricia Russ; Sai H Presley; DunFa Peng; Daniel O Rosenblatt; Frederick R Haselton; Jin-Long Yang; M Kay Washington; Xi Chen; Steven Eschrich; Timothy J Yeatman; Wael El-Rifai; R Daniel Beauchamp; Min S Chang
Journal:  J Clin Invest       Date:  2011-09-12       Impact factor: 14.808

5.  BVES regulates c-Myc stability via PP2A and suppresses colitis-induced tumourigenesis.

Authors:  Bobak Parang; Andrew M Kaz; Caitlyn W Barrett; Sarah P Short; Wei Ning; Cody E Keating; Mukul K Mittal; Rishi D Naik; Mary K Washington; Frank L Revetta; J Joshua Smith; Xi Chen; Keith T Wilson; Thomas Brand; David M Bader; William P Tansey; Ru Chen; Teresa A Brentnall; William M Grady; Christopher S Williams
Journal:  Gut       Date:  2016-01-14       Impact factor: 23.059

6.  Reduced Popdc3 expression correlates with high risk and poor survival in patients with gastric cancer.

Authors:  Deng Luo; Ming-Liang Lu; Gong-Fang Zhao; Hua Huang; Meng-Yao Zheng; Jiang Chang; Lin Lv; Jin-Bo Luo
Journal:  World J Gastroenterol       Date:  2012-05-21       Impact factor: 5.742

Review 7.  Blood Vessel Epicardial Substance (BVES) in junctional signaling and cancer.

Authors:  Bobak Parang; Joshua J Thompson; Christopher S Williams
Journal:  Tissue Barriers       Date:  2018-10-11

8.  Metastatic risk and resistance to BRAF inhibitors in melanoma defined by selective allelic loss of ATG5.

Authors:  María García-Fernández; Panagiotis Karras; Agnieszka Checinska; Estela Cañón; Guadalupe T Calvo; Gonzalo Gómez-López; Metehan Cifdaloz; Angel Colmenar; Luis Espinosa-Hevia; David Olmeda; María S Soengas
Journal:  Autophagy       Date:  2016-07-27       Impact factor: 16.016

9.  The Transition from Gastric Intestinal Metaplasia to Gastric Cancer Involves POPDC1 and POPDC3 Downregulation.

Authors:  Rachel Gingold-Belfer; Gania Kessler-Icekson; Sara Morgenstern; Lea Rath-Wolfson; Romy Zemel; Doron Boltin; Zohar Levi; Michal Herman-Edelstein
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

Review 10.  The Popeye domain containing genes: essential elements in heart rate control.

Authors:  Roland F Schindler; Kar Lai Poon; Subreena Simrick; Thomas Brand
Journal:  Cardiovasc Diagn Ther       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.